Biocoat
Scott D'Amour currently serves as the Chief Financial Officer at Biocoat, a company specializing in biomaterial coatings for medical devices. Prior to this role, Scott held the position of Vice President of Finance and Business Operations at Leidos, where oversight included a $500M business segment. Additional experience includes leadership as Vice President of Finance at Berkshire Grey, where Scott managed finance, IT, and HR functions. At Medtronic, Scott was responsible for global accounting operations and financial support for HeartWare. Previous roles include Senior Financial Officer at Biotage, Chief Financial Officer at BioProcessors, and Senior Director of Finance and Operations at Biotage. Early in the career, Scott began as a Senior Financial Analyst at Applied Biosystems. Scott holds an MBA and MS in Finance from Boston College and a BS in Management from the University of Massachusetts Lowell.
This person is not in any teams
This person is not in any offices
Biocoat
Biocoat Incorporated develops and licenses biomaterial coatings for medical devices that are custom engineered to meet client design parameters. Its specialty is supplying lubricious hydrophilic coatings for medical devices. Our full-service coating solution includes industry-leading coating performance, high-touch customer service, and dip coating equipment that is specifically designed to maximize the coating process. HYDAK® Hydrophilic Coating Advantages * Exceptionally hydrophilic * Lubricious when wet, preventing trauma and tissue abrasion * Abrasion resistant * Very thin, flexible coatings can be applied * Biocompatible * Non-thrombogenic * Prevents adhesion of platelets, proteins, microorganisms * Carrier for bioactive substances to make o anti-bacterial surfaces o anti-thrombogenic surfaces